首页 > 最新文献

Sleep Medicine Reviews最新文献

英文 中文
Assessment tools for population sleep health surveillance in adults: A systematic review of validity and reliability 成人人群睡眠健康监测的评估工具:有效性和可靠性的系统评价。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-02 DOI: 10.1016/j.smrv.2025.102196
Joshua A.H. Way , Erin Mathieu , Josephine Chau , Peter A. Cistulli , Yu Sun Bin
Poor sleep health is a significant public health issue. Population health surveillance systems are important for gathering accurate data to inform public health responses but remain underdeveloped for sleep health assessment globally. We aimed to identify sleep assessment tools and to evaluate their validity and reliability for use in population surveillance.
Three databases (PubMed, EMBASE, and PsycINFO) were searched resulting in 12,350 publications as of July 2025; 187 studies met the inclusion criteria and 60 sleep assessment tools were evaluated for nine measurement properties: content validity, criterion validity, construct validity, internal consistency, reliability, agreement, floor and ceiling effects, responsiveness, and interpretability.
The Insomnia Severity Index had five measurement properties rated positively, the highest among all tools. Two tools assessed all sleep health domains: the Regularity, Satisfaction, Alertness, Timing, Efficiency, Duration (RU-SATED) scale and a 13-item composite measure of sleep health (13-SH).
Most sleep assessment tools lacked adequate validation studies in the adult general population or lacked the ability to capture all dimensions of sleep health. Demonstrating criterion and construct validity of existing tools, developing new tools to measure multidimensional sleep health, or combining items from validated measures with strong measurement properties is warranted for effective sleep health surveillance.
睡眠不健康是一个重大的公共卫生问题。人口健康监测系统对于收集准确数据为公共卫生反应提供信息很重要,但在全球睡眠健康评估方面仍不发达。我们的目的是确定睡眠评估工具,并评估其在人口监测中使用的有效性和可靠性。检索了三个数据库(PubMed, EMBASE和PsycINFO),得出截至2025年7月的12,350篇出版物;187项研究符合纳入标准,对60种睡眠评估工具进行了九项测量属性评估:内容效度、标准效度、结构效度、内部一致性、信度、一致性、下限和上限效应、反应性和可解释性。失眠症严重程度指数有五个测量属性被评为正面,在所有工具中是最高的。两种工具评估所有睡眠健康领域:规律性、满意度、警觉性、时间、效率、持续时间(RU-SATED)量表和13项睡眠健康综合测量(13-SH)。大多数睡眠评估工具缺乏对成年普通人群的充分验证研究,或者缺乏捕捉睡眠健康所有维度的能力。证明现有工具的标准和构建有效性,开发新的工具来测量多维睡眠健康,或将来自验证测量的项目与强测量特性相结合,是有效的睡眠健康监测的必要条件。
{"title":"Assessment tools for population sleep health surveillance in adults: A systematic review of validity and reliability","authors":"Joshua A.H. Way ,&nbsp;Erin Mathieu ,&nbsp;Josephine Chau ,&nbsp;Peter A. Cistulli ,&nbsp;Yu Sun Bin","doi":"10.1016/j.smrv.2025.102196","DOIUrl":"10.1016/j.smrv.2025.102196","url":null,"abstract":"<div><div>Poor sleep health is a significant public health issue. Population health surveillance systems are important for gathering accurate data to inform public health responses but remain underdeveloped for sleep health assessment globally. We aimed to identify sleep assessment tools and to evaluate their validity and reliability for use in population surveillance.</div><div>Three databases (PubMed, EMBASE, and PsycINFO) were searched resulting in 12,350 publications as of July 2025; 187 studies met the inclusion criteria and 60 sleep assessment tools were evaluated for nine measurement properties: content validity, criterion validity, construct validity, internal consistency, reliability, agreement, floor and ceiling effects, responsiveness, and interpretability.</div><div>The Insomnia Severity Index had five measurement properties rated positively, the highest among all tools. Two tools assessed all sleep health domains: the Regularity, Satisfaction, Alertness, Timing, Efficiency, Duration (RU-SATED) scale and a 13-item composite measure of sleep health (13-SH).</div><div>Most sleep assessment tools lacked adequate validation studies in the adult general population or lacked the ability to capture all dimensions of sleep health. Demonstrating criterion and construct validity of existing tools, developing new tools to measure multidimensional sleep health, or combining items from validated measures with strong measurement properties is warranted for effective sleep health surveillance.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102196"},"PeriodicalIF":9.7,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145524273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on “Sleep abnormalities in mouse models of depression: a systematic review” 对“抑郁症小鼠模型中的睡眠异常:系统综述”的评论。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.smrv.2025.102199
ZeLin Zhao , Ying Lin , YunHao Cui
{"title":"Commentary on “Sleep abnormalities in mouse models of depression: a systematic review”","authors":"ZeLin Zhao ,&nbsp;Ying Lin ,&nbsp;YunHao Cui","doi":"10.1016/j.smrv.2025.102199","DOIUrl":"10.1016/j.smrv.2025.102199","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102199"},"PeriodicalIF":9.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Napping and psychiatric disorders: A systematic review 午睡和精神疾病:一项系统综述。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.smrv.2025.102197
Sara Bianchi , Sibylle Mauries , Celia Heiligenstein , Julia Maruani , Pierre A. Geoffroy
Napping is associated with adverse health outcomes in healthy adults. Given limited evidence in psychiatric disorders, this PRISMA-compliant review examined napping across various conditions, including studies on prevalence or clinically relevant outcomes related to disease course.
Among the 8275 records identified from PubMed, Web of Science, and Cochrane Library, 40 were included. Risk of bias was assessed using the Newcastle-Ottawa Scale, RoB 2.0, and ROBINS-I tools, by study design.
Most studies concerned patients with depressive disorders, who often nap more frequently and longer than controls, with plausible differential impact across subpopulations. In some, like pregnant women, napping may represent a risk factor; in others, a negative prognostic marker. Fewer studies suggest napping benefits mood, well-being and memory. In bipolar disorder, napping appears prevalent and may increase the risk of depressive symptoms. Research on schizophrenia spectrum and anxiety disorders research is contradictory but generally shows higher napping prevalence versus controls, and links napping to increased anxiety risk in elderlies. Conversely, napping does not appear specifically associated with eating or neurodevelopmental disorders, although data on the latter remain scarce in adults.
Overall, daytime napping is prevalent in most psychiatric disorders and may represent a risk and/or prognostic factor, deserving systematic clinical assessment.
在健康成人中,午睡与不良健康结果有关。鉴于精神疾病的证据有限,本符合prisma标准的综述检查了各种情况下的午睡,包括与疾病病程相关的患病率或临床相关结果的研究。在PubMed, Web of Science和Cochrane Library中确定的8275条记录中,包括40条。通过研究设计,使用纽卡斯尔-渥太华量表、RoB 2.0和ROBINS-I工具评估偏倚风险。大多数研究关注的是抑郁症患者,他们通常比对照组睡得更频繁、时间更长,在不同亚群之间的影响似乎存在差异。对某些人来说,比如孕妇,午睡可能是一种危险因素;在其他情况下,这是一个负面的预后标志。很少有研究表明午睡对情绪、健康和记忆力有好处。在双相情感障碍中,午睡似乎很普遍,并可能增加抑郁症状的风险。对精神分裂症谱系和焦虑症的研究是相互矛盾的,但总的来说,午睡的患病率高于对照组,并将午睡与老年人焦虑风险增加联系起来。相反,午睡似乎与饮食或神经发育障碍没有特别的联系,尽管后者在成人中的数据仍然很少。总的来说,白天午睡在大多数精神疾病中很普遍,可能是一种风险和/或预后因素,值得系统的临床评估。
{"title":"Napping and psychiatric disorders: A systematic review","authors":"Sara Bianchi ,&nbsp;Sibylle Mauries ,&nbsp;Celia Heiligenstein ,&nbsp;Julia Maruani ,&nbsp;Pierre A. Geoffroy","doi":"10.1016/j.smrv.2025.102197","DOIUrl":"10.1016/j.smrv.2025.102197","url":null,"abstract":"<div><div>Napping is associated with adverse health outcomes in healthy adults. Given limited evidence in psychiatric disorders, this PRISMA-compliant review examined napping across various conditions, including studies on prevalence or clinically relevant outcomes related to disease course.</div><div>Among the 8275 records identified from PubMed, Web of Science, and Cochrane Library, 40 were included. Risk of bias was assessed using the Newcastle-Ottawa Scale, RoB 2.0, and ROBINS-I tools, by study design.</div><div>Most studies concerned patients with depressive disorders, who often nap more frequently and longer than controls, with plausible differential impact across subpopulations. In some, like pregnant women, napping may represent a risk factor; in others, a negative prognostic marker. Fewer studies suggest napping benefits mood, well-being and memory. In bipolar disorder, napping appears prevalent and may increase the risk of depressive symptoms. Research on schizophrenia spectrum and anxiety disorders research is contradictory but generally shows higher napping prevalence versus controls, and links napping to increased anxiety risk in elderlies. Conversely, napping does not appear specifically associated with eating or neurodevelopmental disorders, although data on the latter remain scarce in adults.</div><div>Overall, daytime napping is prevalent in most psychiatric disorders and may represent a risk and/or prognostic factor, deserving systematic clinical assessment.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102197"},"PeriodicalIF":9.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145460448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of non-sedative/hypnotic treatment of obstructive sleep apnoea on the respiratory arousal threshold: a systematic review and meta-analysis 非镇静/催眠治疗阻塞性睡眠呼吸暂停对呼吸唤醒阈值的影响:一项系统回顾和荟萃分析。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-31 DOI: 10.1016/j.smrv.2025.102198
Shane A. Landry , Elly M.P. Howell , Meagan E. Crowther , Daniel J. Tan , Caroline Beatty , Luke D.J. Thomson , Simon A. Joosten , Garun S. Hamilton , Bradley A. Edwards
Contrary to the view that a lower arousal threshold causes greater susceptibility to obstructive sleep apnoea (OSA), the arousal threshold has been shown to decrease following treatment with continuous positive airway pressure (CPAP) therapy. This effect has not been consistently demonstrated with other non-CPAP therapies. We systematically reviewed all randomised and non-randomised trials (of non-hypnotic therapy) for OSA, in which respiratory arousal threshold was quantified both on- and off-treatment. Random effects meta-analysis models were used for all meta-analyses. Our analysis demonstrates that OSA treatment is associated with a significant reduction in the respiratory arousal threshold (standardised mean difference = −0.36 [CI95 % −0.49, −0.22], p < 0.001), however, this effect was highly heterogenous (I2 = 67.6 %). Greater reductions in the arousal threshold are observed in studies with highly efficacious treatment as quantified by larger absolute reductions in the apnoea-hypopnea index (AHI, r2 = 0.26, p = 0.002) and increases in SpO2 nadir (r2 = 0.74, p < 0.001). These data provide support for the notion that reductions in the respiratory arousal threshold occur as an indirect consequence of treatment. Importantly, reductions in the respiratory arousal threshold should be an expected finding in trials in which a treatment has successfully reduced OSA severity.
与较低的唤醒阈值导致阻塞性睡眠呼吸暂停(OSA)易感性的观点相反,唤醒阈值已被证明在持续气道正压通气(CPAP)治疗后降低。这种效果在其他非cpap治疗中尚未得到一致证明。我们系统地回顾了OSA的所有随机和非随机试验(非催眠治疗),其中呼吸唤醒阈值在治疗和治疗结束时都被量化。所有meta分析均采用随机效应meta分析模型。我们的分析表明,OSA治疗与呼吸觉醒阈值的显著降低相关(标准化平均差= -0.36 [CI95 % -0.49, -0.22], p 2 = 67.6%)。在高效治疗的研究中观察到唤醒阈值的更大降低,量化为呼吸暂停低通气指数(AHI, r2 = 0.26, p = 0.002)的更大绝对降低和SpO2最低点的增加(r2 = 0.74, p
{"title":"The effect of non-sedative/hypnotic treatment of obstructive sleep apnoea on the respiratory arousal threshold: a systematic review and meta-analysis","authors":"Shane A. Landry ,&nbsp;Elly M.P. Howell ,&nbsp;Meagan E. Crowther ,&nbsp;Daniel J. Tan ,&nbsp;Caroline Beatty ,&nbsp;Luke D.J. Thomson ,&nbsp;Simon A. Joosten ,&nbsp;Garun S. Hamilton ,&nbsp;Bradley A. Edwards","doi":"10.1016/j.smrv.2025.102198","DOIUrl":"10.1016/j.smrv.2025.102198","url":null,"abstract":"<div><div>Contrary to the view that a lower arousal threshold causes greater susceptibility to obstructive sleep apnoea (OSA), the arousal threshold has been shown to decrease following treatment with continuous positive airway pressure (CPAP) therapy. This effect has not been consistently demonstrated with other non-CPAP therapies. We systematically reviewed all randomised and non-randomised trials (of non-hypnotic therapy) for OSA, in which respiratory arousal threshold was quantified both on- and off-treatment. Random effects meta-analysis models were used for all meta-analyses. Our analysis demonstrates that OSA treatment is associated with a significant reduction in the respiratory arousal threshold (standardised mean difference = −0.36 [CI<sub>95 %</sub> −0.49, −0.22], p &lt; 0.001), however, this effect was highly heterogenous (I<sup>2</sup> = 67.6 %). Greater reductions in the arousal threshold are observed in studies with highly efficacious treatment as quantified by larger absolute reductions in the apnoea-hypopnea index (AHI, r<sup>2</sup> = 0.26, p = 0.002) and increases in SpO<sub>2</sub> nadir (r<sup>2</sup> = 0.74, p &lt; 0.001). These data provide support for the notion that reductions in the respiratory arousal threshold occur as an indirect consequence of treatment. Importantly, reductions in the respiratory arousal threshold should be an expected finding in trials in which a treatment has successfully reduced OSA severity.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102198"},"PeriodicalIF":9.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recreational cannabis use and sleep in the general population: a systematic review and meta-analysis 普通人群的娱乐性大麻使用和睡眠:一项系统回顾和荟萃分析。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.smrv.2025.102189
Fangxiang Mao , Sanne J.W. Hoepel , Mina Shahisavandi , Annemarie I. Luik , Hanan EI Marroun
Cannabis use is often used to improve sleep, yet it remains unclear whether its recreational use, either current or lifetime, is associated with better sleep in the general population. We conducted a systematic review and meta-analysis of 120 studies identified from six databases, excluding studies on medicinal cannabis or clinical samples. Current use was defined as cannabis use within one month, and lifetime use as use in the past year or lifetime. Among 102 observational studies identified, current recreational cannabis use was associated with poorer sleep quality, both short and long sleep duration, more insomnia symptoms, and a later chronotype, compared to non-use. Lifetime use showed similar associations with insomnia and chronotype. Neither current nor lifetime use was linked to daytime sleepiness. These associations were more pronounced among men and younger users. In contrast, no associations between cannabis and sleep quality and duration were observed across 19 experimental studies. Overall, recreational cannabis use was linked to poorer sleep across multiple components in observational studies although these findings may be affected by bias. Given the ethical and practical limitations of long-term trials, integrating well-designed observational and experimental research is essential to fully understand how cannabis use links to sleep.
大麻的使用通常被用来改善睡眠,但目前尚不清楚其娱乐性使用,无论是目前还是终生,是否与普通人群的更好睡眠有关。我们对来自6个数据库的120项研究进行了系统回顾和荟萃分析,排除了药用大麻或临床样本的研究。当前使用定义为一个月内使用大麻,终生使用定义为过去一年或一生中使用大麻。在已确定的102项观察性研究中,与不使用大麻相比,目前娱乐性大麻的使用与较差的睡眠质量、较短的睡眠时间和较长的睡眠时间、更多的失眠症状和较晚的睡眠类型有关。终生使用与失眠和生物钟类型有相似的联系。目前或终生使用都与白天嗜睡无关。这些关联在男性和年轻用户中更为明显。相比之下,在19项实验研究中,大麻与睡眠质量和持续时间之间没有联系。总体而言,在观察性研究中,娱乐性大麻的使用与较差的睡眠有关,尽管这些发现可能受到偏见的影响。考虑到长期试验的伦理和实际限制,整合精心设计的观察和实验研究对于充分了解大麻使用与睡眠的关系至关重要。
{"title":"Recreational cannabis use and sleep in the general population: a systematic review and meta-analysis","authors":"Fangxiang Mao ,&nbsp;Sanne J.W. Hoepel ,&nbsp;Mina Shahisavandi ,&nbsp;Annemarie I. Luik ,&nbsp;Hanan EI Marroun","doi":"10.1016/j.smrv.2025.102189","DOIUrl":"10.1016/j.smrv.2025.102189","url":null,"abstract":"<div><div>Cannabis use is often used to improve sleep, yet it remains unclear whether its recreational use, either current or lifetime, is associated with better sleep in the general population. We conducted a systematic review and meta-analysis of 120 studies identified from six databases, excluding studies on medicinal cannabis or clinical samples. Current use was defined as cannabis use within one month, and lifetime use as use in the past year or lifetime. Among 102 observational studies identified, current recreational cannabis use was associated with poorer sleep quality, both short and long sleep duration, more insomnia symptoms, and a later chronotype, compared to non-use. Lifetime use showed similar associations with insomnia and chronotype. Neither current nor lifetime use was linked to daytime sleepiness. These associations were more pronounced among men and younger users. In contrast, no associations between cannabis and sleep quality and duration were observed across 19 experimental studies. Overall, recreational cannabis use was linked to poorer sleep across multiple components in observational studies although these findings may be affected by bias. Given the ethical and practical limitations of long-term trials, integrating well-designed observational and experimental research is essential to fully understand how cannabis use links to sleep.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102189"},"PeriodicalIF":9.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insomnia in spinal cord injury: A meta-analysis of observational studies 脊髓损伤中的失眠:观察性研究的荟萃分析
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.smrv.2025.102195
Asha Morrison, Diana S. Dorstyn
Sleep problems are frequent following spinal cord injury or disease (SCI/D), however the severity of insomnia - including difficulty falling asleep and staying asleep - is not fully understood. Differing assessment methods, variations in diagnostic criteria, and the characteristics of SCI/D may also impact reported prevalence estimates. This PRISMA-guided review synthesizes the available evidence, with consideration of study-level characteristics. The CINAHL, Embase, MEDLINE and PsycINFO databases were searched on March 22nd, 2024 (updated February 12th, 2025), to identify observational studies with an adult SCI/D sample and a validated measure to assess insomnia symptom severity or aid in diagnosis. Studies were appraised (JBI Critical Appraisal tool) and effect size estimates (proportions) meta-analyzed using a random effects model. Nineteen studies (k) representing 11,879 adults with SCI/D, and reporting requisite methodological parameters, were included. Sixty-one percent (CI: 53%–69%; k = 18) endorsed symptoms of insomnia, with 15% (CI: 14%–16%, k = 1) meeting the criteria for insomnia disorder. Findings show routine sleep assessment is needed throughout the continuum of care. There is also a need to consider insomnia as a potential confound in SCI/D research through the active collection of sleep data. Protocol registered on Open Science Framework (https://osf.io/hfr4v).
睡眠问题是脊髓损伤或疾病(SCI/D)后常见的问题,然而失眠的严重程度——包括入睡和保持睡眠困难——尚未完全了解。不同的评估方法,不同的诊断标准和SCI/D的特征也可能影响报告的患病率估计。这项prisma引导的综述综合了现有的证据,并考虑了研究水平的特征。于2024年3月22日检索了CINAHL、Embase、MEDLINE和PsycINFO数据库(更新于2025年2月12日),以确定成人SCI/D样本的观察性研究和评估失眠症状严重程度或帮助诊断的有效措施。使用JBI关键评价工具对研究进行评价,并使用随机效应模型对效应大小估计(比例)进行meta分析。纳入了19项研究(k),涉及11,879名患有SCI/D的成年人,并报告了必要的方法参数。61% (CI: 53%-69%, k = 18)的人有失眠症状,15% (CI: 14%-16%, k = 1)的人符合失眠障碍的标准。研究结果表明,在整个护理过程中,需要进行常规睡眠评估。通过积极收集睡眠数据,也有必要将失眠作为SCI/D研究的潜在混淆因素。在开放科学框架(https://osf.io/hfr4v)上注册的协议。
{"title":"Insomnia in spinal cord injury: A meta-analysis of observational studies","authors":"Asha Morrison,&nbsp;Diana S. Dorstyn","doi":"10.1016/j.smrv.2025.102195","DOIUrl":"10.1016/j.smrv.2025.102195","url":null,"abstract":"<div><div>Sleep problems are frequent following spinal cord injury or disease (SCI/D), however the severity of insomnia - including difficulty falling asleep and staying asleep - is not fully understood. Differing assessment methods, variations in diagnostic criteria, and the characteristics of SCI/D may also impact reported prevalence estimates. This PRISMA-guided review synthesizes the available evidence, with consideration of study-level characteristics. The CINAHL, Embase, MEDLINE and PsycINFO databases were searched on March 22nd, 2024 (updated February 12th, 2025), to identify observational studies with an adult SCI/D sample and a validated measure to assess insomnia symptom severity or aid in diagnosis. Studies were appraised (JBI Critical Appraisal tool) and effect size estimates (proportions) meta-analyzed using a random effects model. Nineteen studies (<em>k</em>) representing 11,879 adults with SCI/D, and reporting requisite methodological parameters, were included. Sixty-one percent (CI: 53%–69%; <em>k</em> = 18) endorsed symptoms of insomnia, with 15% (CI: 14%–16%, <em>k</em> = 1) meeting the criteria for insomnia disorder. Findings show routine sleep assessment is needed throughout the continuum of care. There is also a need to consider insomnia as a potential confound in SCI/D research through the active collection of sleep data. Protocol registered on Open Science Framework (<span><span>https://osf.io/hfr4v</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102195"},"PeriodicalIF":9.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of large language models in data extraction from randomized controlled trials in sleep medicine: A proof-of-concept study 睡眠医学随机对照试验数据提取中大语言模型的准确性:一项概念验证研究。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.smrv.2025.102192
Zhen Peng , Xingwei Wu , Zongshi Qin , Suhail A. Doi , Luis Furuya-Kanamori , Yi Hong , Lifeng Lin , Haitao Chu , Chang Xu , Mingkai Liu
This proof-of-concept study examined the performance of two prominent large language model (LLM)-based AI tools, ChatGPT 4o and Claude 3.5, in extracting data for four specific tasks: group size, event count, mean value, and standard deviation. Utilizing an established database that analyzed data extraction errors in systematic reviews on sleep medicine, we tested the ability of both AI tools to extract data from 648 randomized controlled trials (RCTs) using single- and multiple-sentences prompting approaches. The accuracy of the extracted data was compared to error-corrected metadata, with an overall accuracy reaching up to 71.5 % (95 % CI: 69.3 %, 73.7 %) for Claude and 69.1 % (95 % CI: 66.8 %, 71.3 %) for ChatGPT. Claude demonstrated superior performance over ChatGPT across all tasks, with the largest accuracy difference of up to 12.7 % (OR = 1.70, 95 % CI: 1.38, 2.10). The single-sentence prompt led to lower accuracy compared to the multiple-sentences prompts, with the largest percentage difference being −11.0 % (OR = 0.64, 95 % CI: 0.52, 0.78). Both AI tools achieved strong performance in extracting group size data. These findings underscore the potential of AI tools like Claude, especially when combined with effective prompting strategies like multiple-sentences prompts, to assist data extraction in sleep medicine research.
这项概念验证研究检查了两个著名的基于大型语言模型(LLM)的人工智能工具ChatGPT 40和Claude 3.5在为四个特定任务提取数据方面的性能:群体规模、事件计数、平均值和标准差。利用已建立的数据库分析睡眠医学系统评价中的数据提取错误,我们测试了这两种人工智能工具使用单句和多句提示方法从648项随机对照试验(rct)中提取数据的能力。将提取数据的准确性与纠错元数据进行比较,Claude的总体准确性达到71.5% (95% CI: 69.3%, 73.7%), ChatGPT的总体准确性达到69.1% (95% CI: 66.8%, 71.3%)。Claude在所有任务中都表现出优于ChatGPT的性能,最大的准确率差异高达12.7% (OR = 1.70, 95% CI: 1.38, 2.10)。与多句提示相比,单句提示的准确率较低,最大的百分比差异为- 11.0% (OR = 0.64, 95% CI: 0.52, 0.78)。这两种人工智能工具在提取群体规模数据方面都取得了很好的表现。这些发现强调了像Claude这样的人工智能工具的潜力,特别是当与多句提示等有效提示策略相结合时,有助于睡眠医学研究中的数据提取。
{"title":"Accuracy of large language models in data extraction from randomized controlled trials in sleep medicine: A proof-of-concept study","authors":"Zhen Peng ,&nbsp;Xingwei Wu ,&nbsp;Zongshi Qin ,&nbsp;Suhail A. Doi ,&nbsp;Luis Furuya-Kanamori ,&nbsp;Yi Hong ,&nbsp;Lifeng Lin ,&nbsp;Haitao Chu ,&nbsp;Chang Xu ,&nbsp;Mingkai Liu","doi":"10.1016/j.smrv.2025.102192","DOIUrl":"10.1016/j.smrv.2025.102192","url":null,"abstract":"<div><div>This proof-of-concept study examined the performance of two prominent large language model <strong>(</strong>LLM)-based AI tools, ChatGPT 4o and Claude 3.5, in extracting data for four specific tasks: group size, event count, mean value, and standard deviation. Utilizing an established database that analyzed data extraction errors in systematic reviews on sleep medicine, we tested the ability of both AI tools to extract data from 648 randomized controlled trials (RCTs) using single- and multiple-sentences prompting approaches. The accuracy of the extracted data was compared to error-corrected metadata, with an overall accuracy reaching up to 71.5 % (95 % CI: 69.3 %, 73.7 %) for Claude and 69.1 % (95 % CI: 66.8 %, 71.3 %) for ChatGPT. Claude demonstrated superior performance over ChatGPT across all tasks, with the largest accuracy difference of up to 12.7 % (OR = 1.70, 95 % CI: 1.38, 2.10). The single-sentence prompt led to lower accuracy compared to the multiple-sentences prompts, with the largest percentage difference being −11.0 % (OR = 0.64, 95 % CI: 0.52, 0.78). Both AI tools achieved strong performance in extracting group size data. These findings underscore the potential of AI tools like Claude, especially when combined with effective prompting strategies like multiple-sentences prompts, to assist data extraction in sleep medicine research.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102192"},"PeriodicalIF":9.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep apnea at the frontier— an integrated multidisciplinary functional framework 睡眠呼吸暂停在前沿-综合多学科功能框架
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.smrv.2025.102190
Garth M. Beache , Barbara Hutchinson , Betty Raman , Paul M. Macey , Nancy Pham , Patricia F. Rodriguez-Lozano , Nancy S. Redeker , Virend K. Somers
In this review, we propose a systems-motivated approach to sleep apnea, as a well characterized disorder illustrative of the sleep-wake process. We advance a framework with mechanistic underpinning of the insulin-resistant cardiometabolic effects of obesity and its putative bi-directional relationship with sleep apnea. Such a physiological construct affords an integrated perspective where pathophysiological outcomes in the brain and heart can be objectively characterized by imaging methods that index functional derangements, including those related to clinical measures of metabolism and ischemia, as well as to translational indices of neurotransmitter signaling. A provocative complexity-analysis network model is explored as a novel formalism for brain macro-phenomena, such as the sleep-wake process, as an emergent property arising from the collective interactions of its micro-constituent very large number of neurons. Clinical management is highlighted at the intersection of guideline-directed cardiometabolic- and sleep- medicine, biopsychosocial interventions, and incorporation of newer pharmacological therapeutic advancements. Together, these disparate developments herald a new functional/physiological synergistic era in sleep medicine.
在这篇综述中,我们提出了一种系统驱动的方法来治疗睡眠呼吸暂停,这是一种典型的睡眠-觉醒过程障碍。我们提出了一个框架与机制基础的胰岛素抵抗心脏代谢的影响肥胖及其假定的双向关系与睡眠呼吸暂停。这样的生理结构提供了一个完整的视角,在这个视角中,大脑和心脏的病理生理结果可以通过成像方法客观地表征,这些成像方法可以指示功能紊乱,包括与代谢和缺血的临床测量相关的功能紊乱,以及神经递质信号的翻译指标。一个具有挑战性的复杂性分析网络模型作为大脑宏观现象的新形式被探索,如睡眠-觉醒过程,作为其微观组成的大量神经元的集体相互作用产生的紧急属性。临床管理强调了指导心脏代谢和睡眠医学,生物心理社会干预和新药物治疗进展的交叉。总之,这些不同的发展预示着睡眠医学的一个新的功能/生理协同时代。
{"title":"Sleep apnea at the frontier— an integrated multidisciplinary functional framework","authors":"Garth M. Beache ,&nbsp;Barbara Hutchinson ,&nbsp;Betty Raman ,&nbsp;Paul M. Macey ,&nbsp;Nancy Pham ,&nbsp;Patricia F. Rodriguez-Lozano ,&nbsp;Nancy S. Redeker ,&nbsp;Virend K. Somers","doi":"10.1016/j.smrv.2025.102190","DOIUrl":"10.1016/j.smrv.2025.102190","url":null,"abstract":"<div><div>In this review, we propose a systems-motivated approach to sleep apnea, as a well characterized disorder illustrative of the sleep-wake process. We advance a framework with mechanistic underpinning of the insulin-resistant cardiometabolic effects of obesity and its putative bi-directional relationship with sleep apnea. Such a physiological construct affords an integrated perspective where pathophysiological outcomes in the brain and heart can be objectively characterized by imaging methods that index functional derangements, including those related to clinical measures of metabolism and ischemia, as well as to translational indices of neurotransmitter signaling. A provocative complexity-analysis network model is explored as a novel formalism for brain macro-phenomena, such as the sleep-wake process, as an emergent property arising from the collective interactions of its micro-constituent very large number of neurons. Clinical management is highlighted at the intersection of guideline-directed cardiometabolic- and sleep- medicine, biopsychosocial interventions, and incorporation of newer pharmacological therapeutic advancements. Together, these disparate developments herald a new functional/physiological synergistic era in sleep medicine.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102190"},"PeriodicalIF":9.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145578691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of intermittent fasting on sleep quality and cardiometabolic health outcomes in adults with overweight/obesity status: a systematic review and meta-analysis of randomized controlled trials 间歇性禁食对超重/肥胖成人睡眠质量和心脏代谢健康结局的影响:随机对照试验的系统回顾和荟萃分析
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.smrv.2025.102193
Yi Ning Yong , Alan J. McCubbin , Denise M. O'Driscoll , Marie-Pierre St-Onge , Maxine P. Bonham
Obesity is associated with several cardiovascular risk factors, including obstructive sleep apnea (OSA) development and poorer sleep quality. While diet-induced weight reduction can improve sleep quality, traditional dietary strategies may be challenging and restrictive to maintain. Intermittent fasting (IF) diets offer an alternative, less prescriptive intervention to improve cardiometabolic health markers, though their specific effects on sleep quality are unclear. This systematic review and meta-analysis assessed the effects of IF on sleep and cardiometabolic outcomes associated with OSA risk among adults with overweight/obesity. Eighteen randomized controlled trials (25 comparisons) that compared IF (n = 15 time-restricted eating (TRE); n = 3 alternate-day modified fasting (ADMF)), vs ad libitum eating were identified. Compared to ad libitum eating, TRE and ADMF interventions produced greater reductions in weight, BMI, fat mass, waist circumference, daily energy intake, and diastolic blood pressure. Sleep quality was assessed as a secondary outcome in 15/16 studies. No overall effects of IF on sleep relative to ad libitum eating were observed, despite improvements in weight. This analysis supports IF interventions as an alternative to continuous energy restriction for improving cardiometabolic health in populations with obesity and sleep disturbances, such as OSA. Studies are needed to specifically evaluate the effects of IF on sleep.
肥胖与几种心血管风险因素有关,包括阻塞性睡眠呼吸暂停(OSA)的发展和较差的睡眠质量。虽然饮食引起的减肥可以改善睡眠质量,但传统的饮食策略可能具有挑战性和限制性。间歇性禁食(IF)饮食为改善心脏代谢健康指标提供了一种替代方法,尽管其对睡眠质量的具体影响尚不清楚。本系统综述和荟萃分析评估了IF对超重/肥胖成人睡眠和与OSA风险相关的心脏代谢结果的影响。18个随机对照试验(25个比较)比较了IF (n = 15限时饮食(TRE);n = 3例隔日改良禁食(ADMF)和自由进食。与随意进食相比,TRE和ADMF干预在体重、BMI、脂肪量、腰围、每日能量摄入和舒张压方面产生了更大的降低。在15/16项研究中,睡眠质量被评估为次要结果。尽管体重有所改善,但没有观察到IF对睡眠的总体影响相对于随意饮食。该分析支持IF干预作为持续能量限制的替代方案,可改善肥胖和睡眠障碍(如OSA)人群的心脏代谢健康。还需要研究来具体评估干扰素对睡眠的影响。
{"title":"The effects of intermittent fasting on sleep quality and cardiometabolic health outcomes in adults with overweight/obesity status: a systematic review and meta-analysis of randomized controlled trials","authors":"Yi Ning Yong ,&nbsp;Alan J. McCubbin ,&nbsp;Denise M. O'Driscoll ,&nbsp;Marie-Pierre St-Onge ,&nbsp;Maxine P. Bonham","doi":"10.1016/j.smrv.2025.102193","DOIUrl":"10.1016/j.smrv.2025.102193","url":null,"abstract":"<div><div>Obesity is associated with several cardiovascular risk factors, including obstructive sleep apnea (OSA) development and poorer sleep quality. While diet-induced weight reduction can improve sleep quality, traditional dietary strategies may be challenging and restrictive to maintain. Intermittent fasting (IF) diets offer an alternative, less prescriptive intervention to improve cardiometabolic health markers, though their specific effects on sleep quality are unclear. This systematic review and meta-analysis assessed the effects of IF on sleep and cardiometabolic outcomes associated with OSA risk among adults with overweight/obesity. Eighteen randomized controlled trials (25 comparisons) that compared IF (n = 15 time-restricted eating (TRE); n = 3 alternate-day modified fasting (ADMF)), <em>vs ad libitum</em> eating were identified. Compared to <em>ad libitum</em> eating, TRE and ADMF interventions produced greater reductions in weight, BMI, fat mass, waist circumference, daily energy intake, and diastolic blood pressure. Sleep quality was assessed as a secondary outcome in 15/16 studies. No overall effects of IF on sleep relative to <em>ad libitum</em> eating were observed, despite improvements in weight. This analysis supports IF interventions as an alternative to continuous energy restriction for improving cardiometabolic health in populations with obesity and sleep disturbances, such as OSA. Studies are needed to specifically evaluate the effects of IF on sleep.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102193"},"PeriodicalIF":9.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative adverse events in patients with obstructive sleep apnea undergoing ambulatory ENT surgery: A systematic review and meta-analysis 梗阻性睡眠呼吸暂停患者行门诊耳鼻喉科手术的围手术期不良事件:系统回顾和荟萃分析
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.smrv.2025.102194
Felicia Ceban , Andy Cui , Aparna Saripella , Subin Park , Felix Hu , Nethmi Rajapakse , Ellene Yan , Marina Englesakis , Michael J. Hutz , Basem Abdelmalak , Frances Chung

Objective

Patients with obstructive sleep apnea (OSA) may be at increased risk for adverse events during ambulatory otorhinolaryngologic (ear, nose, and throat, [ENT]) surgery. There remains a gap in the literature quantifying these risks. This systematic review and meta-analysis aimed to evaluate the incidence of perioperative complications among patients with OSA undergoing ambulatory ENT surgeries.

Methods

We systematically searched five databases from inception until February 2024 for studies on adult OSA patients undergoing ambulatory ENT surgeries. Primary outcomes included rates of composite adverse events, same-day admissions, emergency department (ED) visits, and readmissions. Meta-analysis, sensitivity analyses, and meta-regression were performed.

Results

Sixteen studies (5453 patients) were included. The pooled incidence of composite adverse events was 10 % (95 % CI 7–14 %), with 12 % requiring same-day admission, 7 % presenting to the ED, and a 3 % readmission rate. Adverse events were mostly bleeding, pain, and dehydration. Expansion sphincter pharyngoplasty and other combined/multi-level procedures were generally associated with the most complications.

Conclusion

Our findings suggest that ENT procedures may be safely performed in ambulatory settings in appropriately selected patients with OSA. Improved patient selection and perioperative management may reduce complications, and careful risk stratification remains essential, particularly for combined/multi-level airway surgeries.
目的:阻塞性睡眠呼吸暂停(OSA)患者在门诊耳鼻喉科(耳鼻喉科)手术中发生不良事件的风险可能增加。在量化这些风险的文献中仍然存在空白。本系统综述和荟萃分析旨在评估接受门诊耳鼻喉科手术的OSA患者围手术期并发症的发生率。方法系统检索5个数据库,从建立到2024年2月,收集成人OSA患者门诊耳鼻喉科手术的相关研究。主要结局包括复合不良事件发生率、当日入院率、急诊科(ED)就诊率和再入院率。进行meta分析、敏感性分析和meta回归。结果共纳入16项研究(5453例)。综合不良事件的总发生率为10% (95% CI 7 - 14%),其中12%需要当天入院,7%到急诊科就诊,3%再入院。不良事件主要为出血、疼痛和脱水。扩张括约肌咽成形术和其他联合/多层手术通常与最多的并发症相关。结论:我们的研究结果表明,在适当选择的OSA患者中,耳鼻喉科手术可以在门诊环境中安全进行。改进患者选择和围手术期管理可以减少并发症,仔细的风险分层仍然是必要的,特别是对于联合/多级气道手术。
{"title":"Perioperative adverse events in patients with obstructive sleep apnea undergoing ambulatory ENT surgery: A systematic review and meta-analysis","authors":"Felicia Ceban ,&nbsp;Andy Cui ,&nbsp;Aparna Saripella ,&nbsp;Subin Park ,&nbsp;Felix Hu ,&nbsp;Nethmi Rajapakse ,&nbsp;Ellene Yan ,&nbsp;Marina Englesakis ,&nbsp;Michael J. Hutz ,&nbsp;Basem Abdelmalak ,&nbsp;Frances Chung","doi":"10.1016/j.smrv.2025.102194","DOIUrl":"10.1016/j.smrv.2025.102194","url":null,"abstract":"<div><h3>Objective</h3><div>Patients with obstructive sleep apnea (OSA) may be at increased risk for adverse events during ambulatory otorhinolaryngologic (ear, nose, and throat, [ENT]) surgery. There remains a gap in the literature quantifying these risks. This systematic review and meta-analysis aimed to evaluate the incidence of perioperative complications among patients with OSA undergoing ambulatory ENT surgeries.</div></div><div><h3>Methods</h3><div>We systematically searched five databases from inception until February 2024 for studies on adult OSA patients undergoing ambulatory ENT surgeries. Primary outcomes included rates of composite adverse events, same-day admissions, emergency department (ED) visits, and readmissions. Meta-analysis, sensitivity analyses, and meta-regression were performed.</div></div><div><h3>Results</h3><div>Sixteen studies (5453 patients) were included. The pooled incidence of composite adverse events was 10 % (95 % CI 7–14 %), with 12 % requiring same-day admission, 7 % presenting to the ED, and a 3 % readmission rate. Adverse events were mostly bleeding, pain, and dehydration. Expansion sphincter pharyngoplasty and other combined/multi-level procedures were generally associated with the most complications.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that ENT procedures may be safely performed in ambulatory settings in appropriately selected patients with OSA. Improved patient selection and perioperative management may reduce complications, and careful risk stratification remains essential, particularly for combined/multi-level airway surgeries.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102194"},"PeriodicalIF":9.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Sleep Medicine Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1